BAMCO Inc’s Aratana Therapeutics, Inc. PETX Stock Holding History

BAMCO Inc’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-6,360	Closed	-$121K	–	374
2013 Q4	$121K	Buy	+6,360	New	+$129K	﹤0.01%	339

Other funds holding PETX

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

BAMCO Inc's PETX Position: Q1 2014 in Review

BAMCO Inc sold out of Aratana Therapeutics, Inc. (PETX) in Q1 2014, closing a stake of 6,360 shares — an estimated $121K sold.

BAMCO Inc first reported a position in PETX in Q4 2013 and held it in 1 quarter. The position peaked at $121K in Q4 2013. 81 funds tracked by Wall St. Rank hold PETX as of Q1 2014.

BAMCO Inc reported no remaining Aratana Therapeutics, Inc. position as of Q1 2014 after selling out during the quarter.
BAMCO Inc sold 6,360 Aratana Therapeutics, Inc. shares in Q1 2014, an estimated $121K.
BAMCO Inc first reported a position in Aratana Therapeutics, Inc. in Q4 2013 and held it in 1 quarter.
BAMCO Inc's Aratana Therapeutics, Inc. position peaked at $121K in Q4 2013.
81 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q1 2014.

Based on BAMCO Inc's 13F filing for Q1 2014, filed 15 May 2014.